breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Carcinoma in situ of breast, intraductal
DOID EFO Endpoint Browser PheWeb
CD2_INSITU_BREAST_INTRADUCTAL
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3697 |
4. Check minimum number of eventsNone |
3697 |
5. Include endpointsNone |
3697 |
6. Filter based on genotype QC (FinnGen only) |
3345 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D05
- Name in latin
- Carcinoma in situ intraductale mammae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, intraductal
based on the number of shared cases.
Similar with more cases:
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3345 | 3345 | - |
| Unadjusted period prevalence (%) | 1.19 | 1.19 | - |
| Median age at first event (years) | 60.67 | 60.67 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3461
- Matched controls
- 34610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
8.8
310.9
416
530
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
307.7
465
608
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
7.7
307.7
1071
1896
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
86.9
307.7
537
73
TQW20
NOMESCO Finland
Tatoe
20.9
307.7
419
227
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
9.8
307.7
478
555
ZZR10
NOMESCO Finland
Flap of skin and muscle
21.5
307.7
245
122
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
89.9
307.7
227
27
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
16.3
307.7
1199
1093
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.0
307.7
596
786
HAC20
NOMESCO Finland
Total mastectomy
13.6
307.7
1093
1140
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
21.1
307.7
558
312
HA1AA
NOMESCO Finland
X-ray mammography
10.1
307.7
1681
2969
PJA12
NOMESCO Finland
Sentinel node biopsy
23.6
307.7
2281
2621
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
11.9
307.7
1183
1453
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
10.3
307.7
415
450
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
4503599627370496.0
307.7
3459
8
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.3
307.7
679
1292
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
630.2
307.7
1701
53
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
7.2
307.7
577
932
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
7.9
307.7
919
1508
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
10.6
307.7
583
649
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
21.9
307.7
509
270
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
70.8
307.7
280
43
C50
ICD-10 Finland
Malignant neoplasm of breast
8.7
307.7
534
710
C50.99
ICD-10 Finland
Breast, unspecified
7.9
307.7
564
834
HAB40
NOMESCO Finland
Wedge excision of mammary gland
11.5
307.7
1278
1670
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.0
307.7
1391
2393
HAB99
NOMESCO Finland
Other partial excision of mammary gland
13.7
307.7
709
639
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
11.5
307.7
574
587
115
Kela drug reimbursment
Breast cancer
6.3
307.7
1323
3112
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
27.6
303.9
208
80
X76
ICPC
Malignant neoplasm breast female
8.2
293.5
418
573
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
9.8
286.6
348
391
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
276.3
862
2439
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
275.6
1376
5381
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
7.7
275.6
412
596
L02BG04
ATC
letrozole; oral
4.4
273.2
834
2320
D05.0
ICD-10 Finland
Lobular carcinoma in situ
60.7
271.1
151
26
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
30.2
268.7
178
62
HAE99
NOMESCO Finland
Other reconstruction of breast
16.6
265.5
227
146
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.9
261.2
515
989
L02BA01
ATC
tamoxifen; oral
5.4
260.0
575
1226
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
26.8
257.7
178
70
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
23.1
254.3
186
85
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.2
252.9
321
381
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
8.6
243.2
325
411
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
7.1
241.0
385
597
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
39.9
226.2
138
36
N63
ICD-10 Finland
Unspecified lump in breast
4.3
221.5
677
1864
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
19.2
220.1
174
95
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
8.3
215.0
296
387
ZZF00
NOMESCO Finland
Graft of adipose tissue
14.1
213.8
199
149
WZC00
NOMESCO Finland
Treatment plan or consultation
2.7
179.3
1852
10287
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
11.5
173.6
183
167
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.5
171.0
455
1116
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
7.0
169.5
268
408
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
9.3
168.2
208
237
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
9.3
158.6
196
223
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
40.1
147.9
90
23
H02AB02
ATC
dexamethasone; systemic
3.0
146.8
805
3166
XX1XN
NOMESCO Finland
Other isotope examination
9.7
145.5
173
187
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.9
144.7
478
1370
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.2
142.3
308
634
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
6.4
141.6
243
402
Z31.5
ICD-10 Finland
Genetic counselling
4.2
140.6
417
1105
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
11.3
138.6
147
135
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
4.7
138.5
346
803
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
8.0
137.0
190
249
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.8
135.8
325
728
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
6.4
127.3
220
366
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
27.0
127.0
87
33
HA1SA
NOMESCO Finland
Expansion mammography
14.9
124.0
111
77
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
35.3
120.7
76
22
TQB05
NOMESCO Finland
Puncture of skin of trunk
9.2
119.4
147
166
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
397.2
116.3
116
*
WX402
NOMESCO Finland
General anaesthesia
2.4
114.2
1108
5690
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.2
111.9
196
330
WX702
NOMESCO Finland
Supraglottic ventilation device
3.6
109.6
399
1212
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
15.4
109.5
96
64
HAD99
NOMESCO Finland
Other plastic operation on breast
10.3
109.2
123
123
N64.5
ICD-10 Finland
Other signs and symptoms in breast
4.7
109.0
263
591
A04AA02
ATC
granisetron; systemic, transdermal
3.3
105.7
448
1497
L03AA13
ATC
pegfilgrastim; parenteral
3.5
105.2
389
1193
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
4.5
104.8
273
652
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
4.6
104.6
264
615
HAD40
NOMESCO Finland
Mastopexy
11.9
102.7
105
91
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.8
98.2
325
924
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
5.3
97.7
203
401
N64.9
ICD-10 Finland
Disorder of breast, unspecified
7.1
97.3
149
218
ZX080
NOMESCO Finland
Image guided radiotherapy
5.1
96.1
208
426
N60.8
ICD-10 Finland
Other benign mammary dysplasias
14.4
94.8
86
61
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.7
92.7
221
491
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
92.4
1172
6619
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
5.0
92.1
204
426
X21
ICPC
Breast sympt/compl female other
4.7
91.5
223
504
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
5.4
91.0
186
362
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
8.2
87.1
117
147
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.2
86.6
185
374
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
11.1
85.3
91
84
WZC30
NOMESCO Finland
Teaching
2.3
82.6
805
4061
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
5.8
78.3
147
264
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
10.7
78.0
85
81
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
13.5
77.7
73
55
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
9.8
77.4
90
94
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
9.1
77.2
95
107
A04AA55
ATC
palonosetron, combinations; systemic
3.3
74.4
306
997
ZXA05
NOMESCO Finland
Left side
2.0
74.0
1079
6319
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
12.2
73.8
74
62
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
73.3
1489
9759
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
5.4
73.0
146
278
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
70.7
243
706
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
6.8
70.5
111
167
HAD20
NOMESCO Finland
Liposuction of breast
17.8
68.9
56
32
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
9.5
66.4
79
85
QBJ00
NOMESCO Finland
Liposuction in trunk
8.6
66.2
85
101
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
105.0
66.1
72
7
HA1HA
NOMESCO Finland
Tomosynthesis mammography
6.6
65.6
106
164
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
9.0
65.3
81
92
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
65.1
333
1228
L02BG06
ATC
exemestane; oral
4.0
63.7
190
500
ZXA00
NOMESCO Finland
Right side
1.9
63.7
1121
6935
D24
ICD-10 Finland
Benign neoplasm of breast
4.1
63.5
179
452
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
12.3
63.4
63
52
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.6
63.3
123
228
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
25.6
61.5
43
17
R4110
NOMESCO Finland
Physiotherapy
1.9
61.2
1175
7456
ZSZ00
NOMESCO Finland
Primary repair operation
163.0
61.1
64
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
60.4
1035
6326
NK6AN
NOMESCO Finland
Total body bone isotope imaging
4.3
58.0
156
380
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
56.9
1694
12181
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.7
55.7
131
287
A04AD12
ATC
aprepitant; systemic
3.8
55.1
177
490
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
8.5
54.9
71
85
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
6.8
53.1
84
127
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
3.8
53.1
169
465
HAA10
NOMESCO Finland
Biopsy of mammary gland
6.1
52.3
92
155
HAD00
NOMESCO Finland
Augmentation mammoplasty
18.8
49.2
39
21
X26
ICPC
Fear of breast cancer female
5.9
47.2
86
150
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.2
47.2
425
2038
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
6.5
45.6
75
118
HA1S1
NOMESCO Finland
Photography of breasts
10.8
43.5
47
44
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.1
43.3
92
185
D05
ICD-10 Finland
Carcinoma in situ of breast
222.8
43.0
44
*
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
56.3
42.5
50
9
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
42.1
307
1342
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
8.4
41.6
54
65
X19
ICPC
Breast lump/mass female
3.8
40.3
127
347
HA1AE, ,
SPAT
2.8
40.2
208
768
8500/2-C50.5
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast
402.1
40.2
40
*
WZC15, ,
NOMESCO Finland
5.5
39.4
76
140
Z3231
NOMESCO Finland
Registered nurse
1.7
39.3
981
6548
1CD02, ,
NOMESCO Finland
4.5
38.6
94
212
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
8.6
37.0
47
55
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.6
36.4
123
352
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
8.1
35.8
48
60
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
35.6
1416
10547
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
6.1
35.3
61
101
L02BG03
ATC
anastrozole; oral
3.1
34.8
145
474
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
5.3
34.5
70
135
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
6.8
34.0
53
79
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.3
33.6
87
206
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
6.8
33.5
52
77
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
8.0
33.2
45
57
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
5.0
32.9
70
141
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
5.5
32.9
64
119
B01AB05
ATC
enoxaparin; parenteral
1.6
32.6
1227
8978
8500/2-C50.2
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast
320.0
31.9
32
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
3.3
31.3
121
378
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
30.8
463
2650
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
30.5
196
806
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
4.9
30.4
67
139
N62
ICD-10 Finland
Hypertrophy of breast
2.3
30.4
229
1013
N02BE01
ATC
paracetamol; systemic, rectal
2.2
30.2
3224
29818
FM1FN
NOMESCO Finland
Heart function isotope examination
5.2
29.7
61
119
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
3.8
29.3
91
246
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
8.9
28.9
36
41
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
28.8
431
2460
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
3.9
28.7
84
218
XX2VW
NOMESCO Finland
Radiologic consultation
5.7
28.6
53
94
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
5.6
28.5
54
98
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
28.3
211
929
Z51.0
ICD-10 Finland
Radiotherapy session
4.0
27.1
78
200
Z3226
NOMESCO Finland
Physiotherapist
1.6
27.0
668
4389
XX2RW, ,
NOMESCO Finland
3.7
26.9
85
233
8500/2-C50.3
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast
273.2
26.8
27
*
HA5CB
NOMESCO Finland
Galactography
8.6
26.6
34
40
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
5.5
26.5
51
94
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.4
26.4
95
284
HAB20
NOMESCO Finland
Excision of lactiferous duct
7.6
26.3
37
49
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
5.2
26.0
53
103
N64.8
ICD-10 Finland
Other specified disorders of breast
5.2
25.7
53
104
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
2.4
25.6
186
809
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
6.8
25.0
39
58
WF002
NOMESCO Finland
Radical radiotherapy
2.6
24.7
150
601
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
5.2
24.5
50
97
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
4.7
24.5
56
120
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
+∞
24.0
23
*
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
6.8
23.8
37
55
ZXE00
NOMESCO Finland
One hour or less
1.5
23.5
1317
10280
HA4GT
NOMESCO Finland
Labeling mammary gland pathology with galactographic guidance
8.9
23.3
29
33
ZX112
NOMESCO Finland
Subcutaneous
3.0
22.6
100
339
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.5
22.4
55
125
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
22.4
232
1166
N06AX16
ATC
venlafaxine; oral
1.6
22.3
566
3727
HAC25
NOMESCO Finland
Radical mastectomy
5.4
22.1
43
80
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.3
22.0
44
84
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
21.8
127
499
9703
FHL
Breast resection
3.7
21.6
69
191
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
8.8
21.5
27
31
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
4.1
21.1
58
144
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.0
20.8
91
307
8504/2-C50.9
ICD-O-3
Encapsulated papillary carcinoma of breast, NOS
211.2
20.6
21
*
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
30.2
20.5
27
9
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
5.2
20.5
42
82
L02AE03
ATC
goserelin; implant
4.1
20.1
55
136
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.6
20.1
67
191
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.9
20.0
93
325
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
4.6
19.8
47
104
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
5.9
19.6
35
60
8500/2-C50.1
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast
+∞
18.8
18
*
XX2ET, ,
NOMESCO Finland
18.8
18.6
28
15
JN4BD
NOMESCO Finland
Extensive body CT
1.7
18.6
349
2120
G02CX06, ,
ATC
7.9
18.3
25
32
J01DB01
ATC
cefalexin; oral
1.5
18.2
2815
25770
ZZS55
NOMESCO Finland
Distension of tissue expander
44.2
18.2
22
5
PJW99
NOMESCO Finland
Other operation on lymphatic system
4.2
17.9
47
113
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
17.6
1583
13198
8500/2-C50.8
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast
180.9
17.5
18
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
5.0
17.1
36
72
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.2
17.1
141
649
1XC03, ,
NOMESCO Finland
4.7
17.0
39
84
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
7.2
16.9
25
35
ZX120
NOMESCO Finland
Intravenous
1.7
16.9
329
2017
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
6.3
16.7
28
45
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
5.2
16.3
33
64
L02AE02
ATC
leuprorelin; implant, parenteral
3.6
16.0
52
146
XX1AD
NOMESCO Finland
Other CT-examination
4.2
15.8
42
102
S18
ICPC
Laceration/cut
1.3
15.8
1617
13671
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
15.7
2420
21751
A79
ICPC
Malignancy NOS
2.9
15.4
73
258
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
14.8
247
1450
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
3.8
14.7
44
117
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
4.0
14.6
41
104
8543/3-C50.1
ICD-O-3
Paget disease and intraductal carcinoma of breast of central portion of breast
150.6
14.5
15
*
L03AA14
ATC
lipegfilgrastim; parenteral
2.3
14.0
101
440
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.6
13.8
315
2011
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
13.7
3101
29328
WX704
NOMESCO Finland
Intubation
1.7
13.6
288
1803
OAA41
NOMESCO Finland
Health check based on individual needs
4.8
13.5
30
63
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
4.1
13.5
37
92
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.3
13.5
50
153
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
13.5
119
563
A04AA01
ATC
ondansetron; systemic, rectal
1.6
13.5
337
2198
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.1
13.4
26
26
HA4BT
NOMESCO Finland
Breast seed implant placement under ultrasound guidance
12.9
13.4
23
18
394
Kela drug reimbursment
Palbociclib
3.6
13.3
44
125
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
4.7
13.3
30
64
YX9AW, ,
NOMESCO Finland
4.6
13.3
31
68
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.7
13.1
69
259
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
13.0
191
1080
1501
Kela drug reimbursment
Palbociclib
3.4
12.9
45
133
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
3.3
12.8
47
143
L03AA02
ATC
filgrastim; parenteral
2.1
12.7
119
577
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
12.5
222
1326
M05BX04
ATC
denosumab; parenteral
1.6
12.5
287
1833
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.6
12.2
68
263
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
18.1
12.0
18
10
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
12.0
141
742
SPAT1269
SPAT
Other puncture and/or drainage
4.0
11.9
33
83
HA1BA
NOMESCO Finland
Extensive X-ray mammography
3.2
11.9
45
140
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.4
11.5
483
3506
8503/2-C50.4
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast
120.4
11.4
12
*
JN4AD
NOMESCO Finland
Body CT examination
1.5
11.3
364
2508
ZXA10
NOMESCO Finland
Bilateral
1.4
11.3
609
4617
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
11.8
11.3
20
17
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
2.8
11.2
53
188
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.0
11.1
48
162
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
4.2
11.1
29
70
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
11.1
69
282
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
10.9
70
290
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.9
10.8
50
175
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
11.9
10.8
19
16
Z2221
NOMESCO Finland
Medical doctor
1.3
10.5
851
6858
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
3.6
10.3
33
92
D50.1
ICD-10 Finland
Sideropenic dysphagia
23.4
10.2
14
6
ZZR70
NOMESCO Finland
Perforator flaps
23.4
10.2
14
6
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
3.1
10.1
40
128
HA1RA, ,
SPAT
1.6
10.1
217
1363
HA1AA, ,
SPAT
1.8
9.8
133
735
HA1AT, ,
SPAT
4.9
9.8
21
43
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
9.7
323
2242
-1, ,
ICD-10 Finland
1.8
9.4
134
752
HA1DA
NOMESCO Finland
Restricted mammography
7.5
9.4
21
28
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
9.4
239
1565
8501/2-C50.9
ICD-O-3
Comedocarcinoma, noninfiltrating of breast, NOS
+∞
9.4
9
*
5702
FHL
Local lymph node removal (eg armpit, groin)
4.2
9.4
24
57
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
5.2
9.4
19
37
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
9.3
663
5234
QBA00
NOMESCO Finland
Puncture of skin of trunk
4.1
9.2
25
62
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.0
9.0
39
132
N61
ICD-10 Finland
Inflammatory disorders of breast
2.1
9.0
79
376
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
8.9
164
991
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
12.5
8.9
15
12
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.8
1022
8593
3AA13, ,
NOMESCO Finland
4.7
8.8
20
43
HA4RT
NOMESCO Finland
Breast seed implant placement under stereotactic guidance
50.1
8.7
10
*
HA1WT, ,
NOMESCO Finland
50.1
8.7
10
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
4.3
8.6
22
52
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.7
8.6
338
4628
ZSZ10
NOMESCO Finland
Secondary repair operation
7.6
8.6
19
25
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
4.4
8.6
21
48
L02BA03
ATC
fulvestrant; parenteral
2.6
8.5
46
176
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
27.6
8.5
11
*
ZZS50
NOMESCO Finland
Insertion of tissue expander
90.3
8.4
9
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
8.4
580
7272
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.1
8.3
78
380
ZXD20
NOMESCO Finland
Day surgery
1.4
8.3
417
3115
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
7.1
8.2
19
27
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
3.6
8.1
26
73
L01EF01
ATC
palbociclib; oral
3.4
8.1
28
83
192
Kela drug reimbursment
Fulvestrant
2.9
8.1
37
130
N60.4
ICD-10 Finland
Mammary duct ectasia
6.8
8.1
19
28
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.5
8.0
47
188
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
4.4
7.9
19
43
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
7.8
294
2088
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.3
7.8
59
264
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
3.4
7.8
27
80
L01BC06
ATC
capecitabine; oral
1.7
7.8
130
767
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
7.6
93
499
SPAT1152
SPAT
Removal of foreign body from under the skin
1.9
7.6
88
464
XX9TE
NOMESCO Finland
Compementary ultrasound examination
2.9
7.6
34
118
8509/2-C50.9
ICD-O-3
Solid papillary carcinoma in situ of breast, NOS
25.1
7.6
10
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
3.6
7.6
24
67
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
7.6
63
294
N60.0
ICD-10 Finland
Solitary cyst of breast
3.0
7.5
32
108
B01AB10
ATC
tinzaparin; parenteral
1.4
7.5
381
2854
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
80.3
7.4
8
*
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
80.3
7.4
8
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
3.3
7.4
27
83
PJ5YQ, ,
NOMESCO Finland
10.9
7.3
13
12
L01XE33
ATC
[U] palbociclib
3.2
7.2
27
84
HA1HA, ,
SPAT
6.2
7.2
18
29
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
15.8
7.2
11
7
A46
ICD-10 Finland
Erysipelas
1.4
7.2
381
2872
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
4.1
7.1
19
47
X79
ICPC
Benign neoplasm breast female
10.0
7.0
13
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
7.0
203
1370
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.2
7.0
58
271
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.5
6.9
241
1689
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
7.5
6.9
15
20
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.3
6.9
47
202
X20
ICPC
Nipple symptom/complaint female
3.8
6.8
20
53
N64.4
ICD-10 Finland
Mastodynia
1.7
6.8
124
751
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
3.8
6.5
19
50
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.7
6.5
120
730
8540/3-C50.0
ICD-O-3
Paget disease, mammary of nipple
70.0
6.4
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
2.7
6.4
33
124
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
2.8
6.4
31
113
A98
ICPC
Health maint/preventive medicine
1.8
6.3
3377
33151
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
6.3
155
1011
D01.5
ICD-10 Finland
Carcinoma in situ: Liver, gallbladder and bile ducts
+∞
6.3
6
*
SPAT1153
SPAT
Removal of sutures
1.2
6.2
985
8510
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
6.2
1665
15123
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.5
6.1
166
1105
ZZR30
NOMESCO Finland
Flap of muscle
4.1
6.1
16
39
HA3RT
NOMESCO Finland
Coagulation of mammary neoplasm under radiological guidance
12.5
6.1
10
8
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.4
6.0
40
170
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
6.0
164
1093
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
10.0
6.0
11
11
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
10.0
6.0
11
11
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
491
992
5.60
234.84
3.5
4.0
36.24
30.81
u/ml
0.23
475
965
311
422
8.00
218.96
1.0
1.1
—
—
—
0
0
2249
15325
2.34
119.11
2.7
2.7
—
—
estimate
—
0
0
2461
18004
2.27
101.39
8.0
6.7
9.69
10.27
umol/l
2.13
2377
17139
3113
25786
3.06
90.29
10.6
8.6
78.31
79.58
u/l
1.00
3030
24432
2499
19134
2.10
80.95
10.4
10.3
3.61
3.91
e9/l
11.94
2214
16608
1820
13072
1.83
64.17
4.8
3.6
2.38
2.37
mmol/l
6.36
1686
11857
1222
8115
1.78
53.07
2.3
2.3
—
—
—
0
0
690
3953
1.93
47.35
3.8
4.1
19.56
22.02
ug/l
0.10
547
3175
239
1050
2.37
32.23
1.2
1.3
—
—
—
0
0
2100
17883
1.44
23.25
6.9
6.9
1.23
1.22
mmol/l
0.66
1812
15426
1905
16057
1.41
21.52
5.9
6.1
1.22
1.22
mmol/l
1.51
1772
14824
507
3338
1.61
19.80
2.0
2.2
0.23
0.21
g/l
9.04
485
3141
3236
30615
1.88
18.57
17.5
15.8
80.18
78.59
ml/min/173m2
6.21
3083
28509
80
287
2.83
16.42
1.1
1.2
—
—
—
0
0
3354
32267
2.28
16.25
19.0
18.5
139.81
139.82
mmol/l
0.09
3313
31705
3412
33113
3.15
15.70
23.6
21.2
68.51
70.00
umol/l
4.33
3390
32750
3354
32320
2.22
15.27
19.3
18.7
3.93
3.94
mmol/l
3.09
3310
31693
1806
15612
1.33
14.71
4.5
4.7
36.37
35.82
g/l
4.46
1669
14597
102
440
2.36
14.41
1.3
1.4
0.51
0.31
nmol/l
1.03
64
298
3392
32928
2.51
13.64
15.4
13.2
23.90
24.01
u/l
0.17
3318
32009
3429
33528
3.46
12.46
27.7
25.0
259.85
263.34
e9/l
2.68
3396
32878
3429
33533
3.44
12.36
27.6
24.9
91.44
91.34
fl
0.65
3412
33202
3429
33535
3.44
12.31
27.7
25.0
6.27
6.52
e9/l
9.24
3388
32754
3429
33535
3.44
12.31
28.1
25.3
39.42
39.87
%
1.61
3412
33192
3429
33535
3.44
12.31
27.7
24.9
4.37
4.39
e12/l
2.73
3385
32758
3429
33540
3.42
12.21
27.9
25.1
131.01
131.90
g/l
4.50
3413
33215
3243
31146
1.65
11.62
16.9
16.1
22.28
21.44
mg/l
0.74
2653
25608
2091
19112
1.24
8.30
4.3
4.6
6.48
6.57
mmol/l
1.52
2003
18161
407
3032
1.39
8.28
2.7
4.2
114.58
65.83
u/ml
0.29
391
2928
1005
8518
1.25
7.95
3.7
3.8
95.79
94.81
%
0.66
980
8309
1901
17278
1.22
7.66
2.6
2.6
81.74
80.77
nmol/l
0.80
1717
15688
895
7720
1.21
5.68
1.5
1.4
—
—
—
0
0
877
7616
1.20
5.11
2.9
2.9
2.47
2.46
mmol/l
0.12
784
6879
415
3326
1.28
5.08
3.1
3.3
—
—
—
0
0
1254
11253
1.18
5.01
3.6
3.3
29.64
31.59
u/l
1.11
1186
10582
1007
11319
0.84
4.78
3.8
4.0
3.46
7.06
mg/mmol
6.34
516
6263
218
1625
1.36
4.48
1.4
1.3
40.32
38.55
iu/l
0.32
189
1415
1000
11189
0.85
4.41
3.2
3.3
19.52
33.36
mg/l
4.07
510
6312
512
4280
1.23
4.34
5.2
5.2
33.54
33.44
%
0.07
314
2782
1042
11557
0.86
4.01
3.1
3.3
6.41
6.37
mmol/l
0.13
858
9650
1706
15899
1.14
3.76
6.0
6.6
27.76
28.64
%
2.59
1605
15026
1677
15617
1.14
3.73
5.9
6.5
56.89
56.63
%
0.38
1583
14877
187
2455
0.75
3.66
2.0
2.3
4.72
6.06
ug/l
0.65
155
2121
62
377
1.66
3.51
1.1
1.2
—
—
—
0
0
1582
14736
1.14
3.38
10.6
12.8
1.15
1.18
inr
1.65
1301
12095
175
1332
1.33
3.22
2.9
3.3
1117.63
721.70
u/ml
0.22
149
1142
354
2943
1.23
3.18
7.2
7.8
117.66
118.46
g/l
0.38
345
2867
2681
25915
1.15
3.07
22.6
20.1
13.63
13.67
%
0.85
2664
25573
122
885
1.39
3.06
1.5
1.6
—
—
—
0
0
75
500
1.51
2.94
1.3
1.4
38.95
39.80
u/l
0.07
69
407
2196
20993
1.13
2.85
3.5
3.3
48.62
44.34
u/l
1.05
2025
19578
124
914
1.37
2.85
4.3
2.3
201.90
196.10
%
0.27
116
876
33
179
1.85
2.82
2.1
2.2
17.59
6.23
ug/l
0.32
23
119
238
1924
1.25
2.79
7.9
8.7
0.75
0.64
%
3.50
238
1913
70
468
1.51
2.73
1.2
1.2
61.30
59.31
u/l
0.13
63
411
120
893
1.36
2.62
2.9
2.4
3.55
3.58
g/l
0.10
113
854
29
156
1.87
2.56
1.2
1.3
—
—
—
0
0
244
2015
1.23
2.40
7.8
8.4
1.24
1.28
%
0.37
244
2002
245
2028
1.22
2.36
7.8
8.5
94.63
94.14
%
0.58
245
2021
59
394
1.51
2.36
1.1
1.3
22.94
21.93
u/l
0.15
52
319
123
940
1.32
2.29
2.9
3.2
2.93
2.39
index
0.27
55
467
657
7274
0.88
2.27
1.7
1.7
68901783.99
34098928.44
pmol/l
0.48
537
6012
567
5062
1.14
2.23
2.9
2.9
4.13
4.39
e6/l
0.18
253
2283
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
26
142
1.84
2.23
10.1
2.3
166.52
138.08
%
0.57
21
134
362
3128
1.18
2.20
7.0
7.5
96.25
95.84
%
0.63
351
3020
15
308
0.48
2.15
1.1
1.1
—
—
—
0
0
11
42
2.62
2.14
1.0
1.0
—
—
—
0
0
66
462
1.44
2.12
1.5
1.4
—
—
—
0
0
69
488
1.42
2.10
1.5
1.4
—
—
—
0
0
1000
10757
0.90
2.08
2.0
2.2
135.25
160.06
u/l
1.31
932
10135
3108
30554
1.17
2.08
6.4
6.4
1.85
1.92
mu/l
2.43
2861
28464
66
464
1.43
2.08
1.5
1.4
—
—
—
0
0
75
1026
0.73
2.05
1.5
1.5
0.55
0.32
mg/l
1.64
32
402
119
1521
0.77
2.03
3.4
3.6
45.31
47.20
%
0.36
119
1495
406
3565
1.16
2.02
6.6
7.0
0.89
1.18
mmol/l
0.85
347
2990
2580
25081
1.11
2.02
4.5
4.9
12.63
13.09
mm/h
0.94
2388
23505
26
147
1.77
2.02
1.5
1.3
—
—
—
0
0
26
147
1.77
2.02
1.5
1.3
—
—
—
0
0
66
467
1.42
2.01
1.5
1.4
—
—
—
0
0
70
501
1.41
2.01
1.5
1.4
—
—
—
0
0
125
980
1.29
1.97
2.4
2.0
95.82
95.51
%
0.05
120
932
360
3149
1.16
1.90
3.0
3.3
76.64
80.92
ng/l
0.50
304
2669
42
275
1.53
1.89
2.3
3.1
—
—
—
0
0
68
492
1.39
1.85
1.6
1.4
—
—
—
0
0
9
35
2.58
1.80
1.9
1.4
—
—
—
0
0
295
2554
1.17
1.79
1.8
1.7
—
—
—
0
0
56
783
0.71
1.79
1.4
1.4
1357.93
1441.03
e6/l
0.03
42
606
628
5727
1.12
1.76
2.9
3.2
0.82
0.81
mmol/l
1.46
582
5359
16
81
1.98
1.74
1.3
1.1
—
—
—
0
0
2255
21848
1.09
1.72
5.1
5.2
2398.50
2765.71
e6/l
0.12
30
274
404
3594
1.14
1.70
6.6
7.0
13.98
12.68
kpa
3.61
389
3447
404
3599
1.14
1.67
6.6
7.0
5.19
5.12
kpa
1.09
389
3458
58
417
1.40
1.67
2.0
2.1
14.83
25.75
mg/l
2.54
23
152
216
2532
0.84
1.66
2.4
3.0
4.53
4.47
kpa
0.16
211
2468
40
585
0.68
1.66
1.1
1.3
—
345.19
—
0
54
40
268
1.50
1.66
1.3
1.2
76.77
87.56
u/l
0.30
35
231
314
2751
1.16
1.65
6.4
6.8
1.30
1.23
mmol/l
0.40
309
2703
448
4021
1.13
1.65
2.5
2.5
9.41
6.89
umol/l
1.11
386
3491
313
2742
1.16
1.65
2.8
2.6
67.44
65.52
ml/min/173m2
0.43
122
1169
56
770
0.72
1.64
1.4
1.3
46.03
28.70
e6/l
0.20
37
554
43
294
1.47
1.62
1.9
4.6
7.06
7.28
mmol/l
0.12
35
252
231
1979
1.18
1.62
1.8
1.7
—
—
—
0
0
1546
14766
1.08
1.62
11.7
11.6
0.01
0.00
e9/l
0.55
1255
11972
5
14
3.57
1.61
1.6
1.5
392.40
641.88
nmol/l
—
5
14
224
2610
0.85
1.61
2.4
2.4
0.26
0.50
e6/l
2.22
212
2475
255
2940
0.86
1.61
2.9
3.5
1.92
2.04
mmol/l
0.20
235
2641
39
264
1.48
1.55
1.3
1.2
10.42
24.37
u/l
2.26
33
219
5
15
3.34
1.52
1.4
1.0
0.00
0.23
u/ml
—
5
10
579
5303
1.11
1.51
2.0
1.9
—
—
—
0
0
39
267
1.47
1.48
1.6
1.5
3.86
6.19
u/l
0.90
28
216
9
39
2.31
1.43
1.0
1.0
—
—
—
0
0
46
328
1.41
1.42
2.9
3.3
59.63
57.37
%
0.29
40
289
69
528
1.31
1.39
2.7
3.4
1.03
1.47
%
1.04
60
479
32
214
1.50
1.38
1.4
1.3
—
—
—
0
0
681
7317
0.91
1.34
2.6
2.7
7.69
7.46
e6/l
0.13
602
6693
122
1472
0.82
1.34
1.5
1.5
—
—
—
0
0
1048
9920
1.08
1.33
2.7
3.0
806.10
1000.62
ng/l
1.77
869
8548
83
657
1.27
1.31
3.3
3.6
30.15
23.84
mg/l
0.79
51
457
23
145
1.59
1.28
1.3
1.6
14.76
15.11
pmol/l
0.13
16
122
199
1723
1.16
1.28
8.8
8.9
15.50
15.71
%
0.50
188
1657
10
48
2.09
1.27
2.2
1.9
—
—
—
0
0
42
574
0.73
1.25
1.8
1.9
1.05
0.83
nmol/l
0.79
33
485
95
1166
0.81
1.25
1.3
1.8
1.17
1.21
g/l
0.68
88
1108
16
92
1.74
1.25
1.3
1.1
77.57
94.74
%
—
7
43
32
220
1.46
1.23
1.4
1.3
—
—
—
0
0
44
595
0.74
1.23
2.5
2.4
118.78
68.70
ug/min
0.23
26
344
10
49
2.04
1.22
2.2
1.9
—
—
—
0
0
37
263
1.41
1.20
1.3
1.4
—
—
—
0
0
10
187
0.53
1.18
1.5
1.5
65.40
74.97
umol/l
—
10
187
434
3974
1.11
1.17
1.8
1.8
—
—
—
0
0
139
1179
1.19
1.16
1.4
1.3
—
—
—
0
0
26
381
0.68
1.16
1.5
1.5
1186.26
1018.96
mu/l
0.50
17
294
291
2610
1.13
1.14
2.7
3.4
4.39
4.45
pmol/l
0.46
259
2330
19
296
0.64
1.14
1.0
1.1
—
—
—
0
0
202
1769
1.15
1.14
1.3
1.4
—
—
—
0
0
1015
9649
1.07
1.13
3.3
3.2
0.05
0.05
0.05
22
232
52
396
1.32
1.13
5.8
6.6
12.50
12.45
mg/l
0.03
52
371
41
301
1.37
1.12
1.3
1.4
122753.69
71932.17
e6/l
0.29
16
151
615
5740
1.09
1.10
2.8
2.8
1.18
1.38
e6/l
0.70
302
2974
804
8508
0.93
1.09
1.3
1.3
1.62
1.64
u/ml
0.01
185
2263
7
138
0.51
1.09
2.0
1.2
—
—
—
0
0
9
162
0.55
1.08
1.0
1.1
1539.89
1664.69
miu/ml
—
9
162
25
169
1.48
1.07
1.1
1.1
—
—
—
0
0
332
3025
1.11
1.01
2.1
2.1
3.11
3.26
ratio
1.89
250
2355
91
1091
0.83
1.00
1.5
1.5
0.32
0.23
iu/ml
0.16
20
195
95
1134
0.83
0.99
1.3
1.8
0.24
0.23
g/l
0.46
88
1076
372
3414
1.10
0.98
2.4
2.4
43.10
39.25
u/l
0.19
305
2843
72
882
0.81
0.98
1.1
1.1
3.22
4.50
—
9
97
663
7035
0.93
0.97
1.3
1.3
9.87
12.86
u/ml
0.59
237
2747
511
4761
1.09
0.97
2.3
2.5
21.65
21.60
%
0.03
467
4405
1269
13174
0.94
0.96
4.0
4.3
4.14
0.47
estimate
0.71
251
2881
11
186
0.59
0.95
1.0
1.1
1.60
1.16
u/l
—
5
89
6
117
0.51
0.94
2.3
1.7
7.78
9.07
ug/l
—
6
117
6
120
0.50
0.93
1.3
1.5
81.90
58.30
ug/l
—
6
120
8
145
0.55
0.92
3.9
4.6
—
—
—
0
0
23
159
1.45
0.91
2.0
2.0
0.59
2.26
u/field
3.41
17
107
230
2552
0.89
0.90
6.2
6.9
9.19
9.21
mmol/l
0.01
216
2448
15
94
1.60
0.90
1.1
1.1
74.33
88.79
%
—
6
42
46
586
0.78
0.90
1.4
1.4
—
—
—
0
0
22
313
0.70
0.89
1.1
1.1
—
85.00
—
0
5
52
412
1.27
0.89
1.7
1.6
60.16
54.46
%
0.48
31
244
322
2958
1.10
0.86
3.4
3.8
1.24
1.24
mmol/l
0.42
288
2550
34
256
1.33
0.84
2.1
2.1
1.42
2.04
u/field
0.50
19
135
8
138
0.58
0.83
1.3
1.1
—
—
—
0
0
6
112
0.53
0.83
2.2
1.2
—
—
—
0
0
21
146
1.44
0.82
2.1
2.4
39.33
44.17
%
0.66
12
82
6
32
1.88
0.81
3.5
6.8
11.30
10.17
%
—
6
32
13
201
0.65
0.81
1.0
1.1
—
—
—
0
0
77
914
0.84
0.80
3.0
2.8
1.39
1.51
mg/l
0.96
72
830
18
122
1.48
0.80
2.3
3.2
1.06
1.67
%
1.10
18
122
27
362
0.74
0.79
1.1
1.1
2.94
3.10
u/ml
0.03
11
143
11
175
0.63
0.78
1.0
1.3
155.18
131.00
nmol/l
0.41
11
175
211
2328
0.90
0.78
1.3
1.3
211.17
168.22
u/ml
0.37
194
2150
34
260
1.31
0.78
2.1
2.7
28.29
26.81
mg/l
0.09
24
174
7
126
0.55
0.77
10.1
13.0
682.86
11148.37
nmol/l
—
7
121
63
521
1.21
0.76
1.6
1.8
2319.09
2768.86
u/l
0.10
18
231
399
3724
1.08
0.76
1.9
1.8
—
—
—
0
0
243
2219
1.10
0.76
1.8
1.8
3.47
3.54
mmol/l
0.40
161
1553
47
581
0.81
0.75
1.1
1.1
2.77
1.32
u/ml
0.55
27
307
19
267
0.71
0.75
1.2
1.4
—
—
—
0
0
1776
17347
1.05
0.73
6.0
6.5
1.78
1.91
e9/l
3.27
1534
15216
248
2703
0.91
0.73
2.3
2.6
70.62
71.33
e9/l
0.12
171
1950
71
598
1.19
0.72
1.2
1.3
—
—
—
0
0
71
598
1.19
0.72
1.2
1.3
—
—
—
0
0
143
1605
0.89
0.72
1.2
1.3
0.20
1.42
u/ml
—
9
146
22
159
1.39
0.72
2.5
2.0
10.15
8.24
mmol/l
0.41
22
159
11
171
0.64
0.72
1.2
1.2
—
—
—
0
0
1843
18024
1.05
0.71
4.0
4.4
0.00
0.30
estimate
0.55
315
3603
36
456
0.79
0.71
1.0
1.1
1.15
1.05
u/ml
0.03
14
179
546
5174
1.07
0.69
2.3
2.5
2.37
2.37
g/l
0.00
483
4775
682
7138
0.94
0.68
1.5
1.5
2.20
2.31
g/l
1.00
352
4173
47
383
1.23
0.68
1.3
1.4
31.35
33.74
g/l
0.66
41
349
1797
17580
1.05
0.67
6.1
6.6
0.18
0.18
e9/l
1.75
1538
15302
191
1738
1.10
0.66
2.4
2.3
0.02
0.00
estimate
0.44
44
556
125
1112
1.13
0.65
1.9
1.8
—
—
—
0
0
21
154
1.37
0.65
3.0
1.8
39.36
40.50
g/l
0.40
21
154
19
137
1.39
0.64
2.3
2.3
—
—
—
0
0
800
7686
1.05
0.64
1.8
1.8
1.12
1.17
mg/l
0.25
617
6001
5
29
1.73
0.64
2.2
1.8
67.40
46.62
umol/l
—
5
29
74
635
1.17
0.63
5.2
4.6
1139.00
303.57
iu/ml
—
8
80
498
4722
1.06
0.63
2.0
2.1
29.00
29.21
s
0.23
478
4591
115
1021
1.13
0.62
2.0
2.8
—
—
—
0
0
42
342
1.23
0.62
1.3
1.4
3124.27
2179.04
e6/l
0.27
30
235
6
101
0.59
0.62
1.2
1.1
—
—
—
0
0
6
104
0.58
0.61
1.0
1.2
—
—
—
0
0
38
467
0.81
0.61
1.0
1.1
8.12
2.18
u/ml
0.64
16
208
746
7761
0.95
0.60
4.1
4.7
1.02
1.21
kg/l
0.50
489
5207
0
20
0.00
0.60
0.0
1.1
—
22.85
—
0
10
128
1425
0.89
0.60
1.7
1.6
13.30
15.93
u/ml
0.22
30
298
92
1044
0.88
0.59
3.9
3.2
1.30
2.88
ratio
2.49
55
591
136
1227
1.11
0.58
1.2
1.4
297.46
283.20
ug/g
0.36
77
719
101
895
1.13
0.57
1.8
1.6
10433.37
10690.19
e6/l
0.03
67
616
41
337
1.22
0.57
1.1
1.2
—
—
—
0
0
94
1061
0.88
0.56
1.6
2.1
315.59
646.20
ug/l
0.81
87
993
23
176
1.31
0.56
3.8
2.2
487.28
485.35
e6/l
0.01
18
136
173
1887
0.91
0.56
2.2
2.9
125.31
127.17
g/l
0.51
165
1827
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
36
439
0.82
0.55
1.1
1.1
32.75
26264.37
iu/ml
—
8
89
1594
15608
1.04
0.54
2.9
3.1
104.82
106.12
ug/l
0.10
1460
14525
1798
17648
1.04
0.54
4.0
4.4
0.01
0.00
estimate
0.66
305
3583
231
2481
0.93
0.53
2.6
2.8
144.75
157.91
ng/l
0.26
208
2285
3119
30988
1.07
0.53
5.4
5.5
5.79
5.87
mmol/l
4.14
2820
28561
6
39
1.54
0.53
1.0
1.7
—
—
—
0
0
9
132
0.68
0.51
10.6
18.1
1126.78
1550.83
nmol/l
—
9
127
1070
10998
0.96
0.51
3.0
2.6
65.90
59.60
u/l
0.86
985
10116
43
361
1.19
0.50
2.1
2.2
1.57
1.12
mmol/l
0.32
43
346
1815
17835
1.04
0.50
4.0
4.4
8.34
3.80
estimate
0.35
324
3756
42
352
1.20
0.50
3.5
3.2
12.74
13.95
index
0.53
27
187
247
2637
0.93
0.49
3.0
3.1
9.95
10.34
g/l
0.67
219
2436
374
3550
1.06
0.49
4.6
4.6
253.65
245.80
u/l
0.34
349
3373
194
2089
0.92
0.49
1.7
1.9
1.16
1.34
g/l
0.78
176
1916
48
561
0.85
0.48
1.1
1.1
2.78
22.31
au/ml
—
10
110
278
2953
0.94
0.48
1.4
1.6
1.34
1.38
%
0.56
234
2576
13
93
1.40
0.48
1.2
1.0
—
—
—
0
0
41
345
1.19
0.47
1.2
1.2
120.83
115.24
pmol/l
0.34
41
345
3207
31907
1.07
0.47
6.2
6.3
2.83
2.82
mmol/l
0.26
2928
29654
50
429
1.17
0.47
1.4
1.4
277.11
273.79
mosm/kgh2o
0.52
37
332
18
233
0.77
0.47
1.5
1.4
0.84
0.98
ratio
—
9
140
18
233
0.77
0.47
1.5
1.4
1.14
1.12
ratio
—
9
140
18
233
0.77
0.47
1.5
1.4
1.20
1.24
ratio
—
9
140
7
48
1.46
0.46
3.3
8.8
5.69
5.35
kpa
—
7
48
22
277
0.79
0.46
1.0
1.1
8.90
9.69
iu/ml
—
5
71
15
199
0.75
0.46
2.9
2.4
784.20
629.57
ml
—
10
144
132
1208
1.10
0.46
2.2
1.9
—
—
—
0
0
810
8352
0.96
0.46
2.5
2.5
312.72
317.10
umol/l
0.64
692
7294
18
232
0.77
0.45
1.5
1.4
—
—
—
0
0
28
229
1.22
0.43
1.2
1.2
—
—
—
0
0
32
383
0.83
0.43
1.1
1.1
5.10
2.98
u/ml
0.30
14
164
324
3406
0.95
0.42
2.5
2.3
389.82
379.17
nmol/l
0.44
294
3161
6
94
0.64
0.42
1.0
1.2
252.00
326.35
pmol/l
—
6
74
3161
31450
1.06
0.42
5.3
5.5
4.92
4.87
mmol/l
1.91
2897
29331
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
3.12
—
0
16
0
16
0.00
0.41
0.0
1.1
—
0.72
—
0
8
36
423
0.85
0.41
1.1
1.1
1.65
1.03
u/ml
0.24
18
199
11
79
1.39
0.40
1.3
1.1
—
—
—
0
0
15
194
0.77
0.40
1.4
1.4
—
—
—
0
0
84
758
1.11
0.40
3.5
3.5
89.77
859.56
u/ml
1.39
73
686
19
238
0.80
0.40
1.5
1.5
66.09
57.50
ug/l
0.54
11
185
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
52
456
1.14
0.39
1.8
1.8
1.58
1.63
mmol/l
0.20
46
446
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
20
248
0.81
0.39
1.1
1.0
315.08
298.33
mg/l
0.48
13
217
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
259
2729
0.94
0.38
1.2
1.2
120.80
144.14
u/ml
0.44
91
1078
37
317
1.17
0.37
2.3
1.5
—
—
—
0
0
159
1484
1.07
0.37
1.4
1.4
—
—
—
0
0
11
147
0.75
0.37
1.2
1.7
—
—
—
0
0
16
202
0.79
0.36
1.4
1.4
—
—
—
0
0
199
1876
1.06
0.36
5.7
6.6
25.01
24.84
mmol/l
0.28
186
1789
9
71
1.27
0.36
7.2
3.2
1.50
1.74
ratio
—
9
65
957
9789
0.97
0.35
3.9
4.6
0.01
0.00
estimate
0.36
301
3470
137
1275
1.08
0.35
4.9
5.3
0.90
0.90
%
0.05
128
1199
5
78
0.64
0.35
1.0
1.1
—
—
—
0
0
622
6407
0.96
0.35
3.5
3.8
67.47
264.37
ng/l
5.73
475
4822
729
7487
0.97
0.35
1.3
1.3
34.28
33.32
iu/ml
0.06
231
2424
6
44
1.36
0.34
1.2
1.0
11.75
6.25
u/ml
—
6
44
110
1188
0.92
0.34
4.0
3.3
47.51
91.31
mg/l
0.44
97
1015
88
806
1.09
0.33
1.1
1.2
0.49
0.60
ratio
2.17
15
147
110
1187
0.92
0.33
4.0
3.3
28.04
39.13
mg/l
1.38
99
1012
126
1352
0.93
0.33
1.7
1.7
1.63
1.61
g/l
0.06
105
1166
104
961
1.08
0.33
1.1
1.2
—
—
—
0
0
33
284
1.16
0.33
3.7
3.7
—
—
—
0
0
23
274
0.84
0.32
2.9
1.5
—
—
—
0
0
23
274
0.84
0.32
2.9
1.5
—
—
—
0
0
23
274
0.84
0.32
2.9
1.5
—
—
—
0
0
39
341
1.15
0.32
2.3
1.5
—
—
—
0
0
103
953
1.08
0.32
1.1
1.2
—
—
—
0
0
28
327
0.86
0.32
1.0
1.0
0.67
0.14
u/ml
0.40
12
103
33
380
0.87
0.31
1.0
1.1
—
—
—
0
0
573
5567
1.04
0.31
2.3
2.5
12.36
12.74
umol/l
0.72
526
5185
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
83
902
0.92
0.30
2.6
3.2
0.36
0.38
iu/ml
0.29
51
503
55
610
0.90
0.30
1.3
1.4
—
—
—
0
0
16
196
0.82
0.30
1.1
1.5
—
—
—
0
0
48
429
1.12
0.29
4.2
3.4
4.42
17.88
nmol/l
0.52
48
413
20
166
1.21
0.29
1.2
1.3
127.72
142.15
mmol/24h
0.48
20
166
15
185
0.81
0.29
1.4
1.4
—
—
—
0
0
10
130
0.77
0.29
1.0
1.5
2.49
3.50
umol/l
—
10
116
90
972
0.92
0.29
2.5
2.1
9.89
12.19
mg/l
2.99
85
903
30
345
0.87
0.29
1.3
1.5
—
—
—
0
0
70
641
1.09
0.28
1.3
1.4
—
—
—
0
0
12
94
1.28
0.28
1.2
1.4
48.29
40.95
%
—
7
58
8
62
1.29
0.28
1.0
1.2
—
—
—
0
0
124
1165
1.07
0.27
1.6
1.8
3.49
4.16
mg/l
0.33
95
896
56
616
0.91
0.27
1.3
1.4
—
—
—
0
0
35
396
0.88
0.27
6.2
5.3
248.51
72.34
u/ml
0.34
11
134
22
258
0.85
0.27
1.0
1.0
395.35
359.85
ng/l
0.21
17
182
15
122
1.23
0.27
1.0
1.2
12.87
11.31
mm/h
0.25
15
122
15
182
0.82
0.26
2.5
2.6
757.60
1292.45
u/ml
0.78
15
182
40
447
0.89
0.26
1.5
1.7
—
—
—
0
0
2729
27133
1.03
0.26
5.2
5.2
14.89
14.85
pmol/l
0.41
2490
25097
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
5
74
0.68
0.26
1.0
1.1
39.10
35.59
iu/ml
—
5
74
5
74
0.68
0.26
1.2
2.1
5.20
6.09
ug/l
—
5
74
67
617
1.09
0.25
3.0
2.6
16.22
16.06
%
0.16
62
611
27
235
1.15
0.25
1.8
1.6
—
—
—
0
0
930
9141
1.02
0.24
3.1
3.2
0.42
0.43
e6/l
0.04
628
6621
860
8445
1.02
0.24
3.6
4.2
0.45
0.18
0.38
11
83
1514
14964
1.02
0.24
2.0
2.0
1.28
1.34
mmol/l
2.39
1227
12446
88
822
1.07
0.24
1.6
2.0
5.40
5.05
mmol/24h
0.50
82
723
3138
31275
1.04
0.23
5.3
5.3
1.64
1.60
mmol/l
5.81
2857
28975
31
275
1.13
0.23
1.2
1.4
1.62
1.48
nmol/l
0.31
26
248
23
264
0.87
0.23
1.0
1.0
52.13
46.98
ng/l
0.20
18
185
67
722
0.93
0.22
1.3
1.4
—
—
—
0
0
5
40
1.25
0.22
13.2
9.9
79.40
69.10
%
—
5
31
487
4754
1.03
0.22
2.2
2.1
101.16
123.69
ug/g
1.35
366
3750
35
314
1.12
0.22
1.7
1.5
136209.59
98623.52
e6/l
0.11
22
205
48
524
0.91
0.22
1.1
1.2
288.54
287.22
u/ml
0.01
30
307
54
586
0.92
0.21
1.2
1.2
3.50
7.30
u/ml
—
6
29
149
1422
1.05
0.21
2.4
2.3
2.94
2.88
g/l
0.24
127
1291
46
420
1.10
0.21
1.1
1.1
1.43
1.50
g/l
0.60
39
374
41
372
1.10
0.21
1.1
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
90
847
1.06
0.21
1.9
1.5
—
—
—
0
0
5
43
1.16
0.21
1.6
2.1
21.00
19.61
umol/l
—
5
43
11
89
1.24
0.21
5.8
4.5
9.61
10.35
kpa
0.54
11
89
69
739
0.93
0.20
1.5
1.7
—
—
—
0
0
17
145
1.17
0.20
1.3
1.5
95.88
269.04
nmol/24h
0.43
17
145
122
1161
1.05
0.20
2.0
1.9
1.74
1.93
ug/l
0.11
105
1037
23
261
0.88
0.20
1.0
1.0
755.33
735.60
ng/l
0.07
18
176
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
2129.00
—
0
9
146
1526
0.95
0.20
2.3
2.0
40.36
40.82
u/l
0.10
128
1371
1236
12215
1.02
0.20
3.8
4.0
98.61
105.56
e6/l
0.18
796
8342
93
983
0.94
0.19
1.2
1.4
—
—
—
0
0
45
489
0.92
0.19
1.4
1.4
—
—
—
0
0
165
1717
0.96
0.19
1.9
1.8
—
—
—
0
0
36
327
1.10
0.19
1.2
1.2
—
—
—
0
0
98
929
1.06
0.19
1.7
1.4
—
—
—
0
0
23
203
1.13
0.19
1.5
1.1
11.20
16.26
u/ml
—
7
85
68
637
1.07
0.19
3.5
3.5
0.72
0.81
nmol/l
0.83
51
511
93
881
1.06
0.18
1.2
1.2
1.68
1.64
g/l
0.82
93
881
23
259
0.89
0.18
1.0
1.1
—
—
—
0
0
3034
30244
1.03
0.18
6.2
6.5
38.66
39.07
mmol/mol
2.73
2786
28250
1063
10500
1.02
0.18
3.1
3.3
65.79
55.04
e6/l
0.12
753
7909
14
119
1.18
0.17
1.2
1.1
549.78
180.48
iu/ml
0.64
14
119
18
205
0.88
0.17
1.2
1.6
—
—
—
0
0
48
516
0.93
0.17
1.2
1.2
30.35
24.20
u/l
0.29
40
440
15
173
0.87
0.16
1.3
1.5
—
—
—
0
0
10
120
0.83
0.16
5.0
1.6
—
—
—
0
0
10
120
0.83
0.16
5.0
1.6
—
—
—
0
0
555
5455
1.02
0.16
1.5
1.5
—
—
—
0
0
1865
18523
1.01
0.16
2.8
2.8
—
—
—
0
0
6
76
0.79
0.15
1.5
1.2
—
—
—
0
0
10
119
0.84
0.15
5.0
1.7
—
—
—
0
0
163
1576
1.04
0.15
1.3
1.4
—
—
—
0
0
80
841
0.95
0.15
1.3
1.3
271.13
228.33
miu/ml
0.40
38
394
85
810
1.05
0.15
1.8
1.5
—
—
—
0
0
13
150
0.87
0.14
1.4
1.7
—
—
—
0
0
17
150
1.13
0.14
1.1
1.1
—
—
—
0
0
125
1205
1.04
0.14
1.8
2.0
4.16
8.64
iu/l
0.46
55
490
100
960
1.04
0.13
2.9
3.6
1.34
1.32
mmol/l
0.09
100
941
105
1010
1.04
0.13
3.5
3.5
25.19
25.14
mmol/l
0.06
93
926
41
438
0.94
0.13
1.1
1.1
5.56
3.79
eliau/ml
0.17
19
180
13
113
1.15
0.13
1.1
1.1
—
—
—
0
0
13
113
1.15
0.13
1.8
1.9
1198.40
10701.81
u/ml
—
5
16
36
335
1.08
0.13
1.6
1.4
—
—
—
0
0
9
110
0.82
0.13
1.1
1.0
—
—
—
0
0
133
1287
1.03
0.13
2.5
2.2
0.39
0.66
g/l
0.79
110
1104
112
1160
0.96
0.12
1.2
1.3
2.13
4.72
u/ml
—
7
127
1538
15478
0.99
0.12
2.2
2.1
102.31
100.00
pmol/l
0.90
696
7360
287
2927
0.98
0.12
2.6
2.6
66.41
66.60
g/l
0.16
254
2679
41
388
1.06
0.10
1.4
1.5
—
—
—
0
0
15
166
0.90
0.09
3.7
1.5
—
—
—
0
0
15
166
0.90
0.09
3.7
1.5
—
—
—
0
0
15
166
0.90
0.09
3.7
1.5
—
—
—
0
0
15
166
0.90
0.09
3.7
1.5
—
—
—
0
0
107
1039
1.03
0.09
1.3
1.3
—
—
—
0
0
5
47
1.06
0.09
1.8
1.6
—
—
—
0
0
23
248
0.93
0.09
1.4
1.5
—
—
—
0
0
185
1889
0.98
0.09
3.6
3.6
5.25
5.18
kpa
0.57
178
1810
113
1162
0.97
0.09
1.2
1.4
3.70
7.66
u/ml
1.27
12
205
2979
29846
0.99
0.09
4.4
4.5
1.25
1.28
mmol/l
1.96
2674
27302
79
763
1.04
0.09
2.5
2.1
126.92
126.05
g/l
0.12
59
575
6
55
1.09
0.08
1.0
1.1
—
—
—
0
0
15
165
0.91
0.08
1.1
1.4
0.63
1.41
nmol/l
—
10
137
27
288
0.94
0.08
1.6
1.6
27.17
22.79
u/ml
—
6
58
18
165
1.09
0.08
1.1
1.5
—
—
—
0
0
18
165
1.09
0.08
1.1
1.5
—
—
—
0
0
20
216
0.93
0.08
1.3
1.6
4.28
8.58
umol/l
2.79
13
145
33
312
1.06
0.08
1.2
1.2
—
—
—
0
0
33
312
1.06
0.08
1.2
1.2
—
—
—
0
0
24
224
1.07
0.08
1.7
1.8
—
—
—
0
0
6
73
0.82
0.07
2.2
1.2
—
—
—
0
0
69
712
0.97
0.07
1.6
1.6
—
—
—
0
0
1226
12320
0.99
0.07
3.4
3.7
38.69
78.68
ng/l
0.51
852
8406
7
83
0.84
0.07
1.0
1.2
—
—
—
0
0
7
85
0.82
0.07
1.0
1.1
—
—
—
0
0
7
85
0.82
0.07
1.4
1.7
20.69
75.72
u/l
—
7
80
110
1075
1.02
0.07
1.7
1.7
—
—
—
0
0
90
877
1.03
0.07
1.1
1.1
4.13
8.28
eliau/ml
0.54
12
98
9
86
1.05
0.07
1.1
1.1
—
—
—
0
0
10
89
1.12
0.06
6.2
4.5
4.97
4.98
kpa
—
10
89
16
173
0.92
0.06
1.0
1.1
—
—
—
0
0
8
95
0.84
0.06
1.0
1.0
—
—
—
0
0
100
977
1.02
0.06
2.3
2.2
0.00
0.00
g/l
-0.00
91
917
39
374
1.04
0.06
1.2
1.2
—
—
—
0
0
54
558
0.97
0.06
1.2
1.3
0.18
0.21
nmol/l
0.33
39
429
155
1575
0.98
0.06
3.4
3.4
2.08
2.01
mmol/l
0.07
126
1230
31
296
1.05
0.05
1.5
1.5
33.69
37.06
%
0.15
18
169
918
9226
0.99
0.05
3.5
3.7
1.03
0.25
estimate
0.38
258
2898
32
306
1.05
0.05
1.2
1.2
—
—
—
0
0
79
809
0.98
0.05
3.1
3.8
3.73
3.78
mmol/l
0.59
79
804
433
4363
0.99
0.05
4.2
5.0
1.04
1.04
mmol/l
0.05
395
3997
30
287
1.05
0.05
1.4
1.5
89.79
89.01
ng/l
0.02
30
287
31
297
1.04
0.05
1.2
1.2
—
—
—
0
0
12
110
1.09
0.05
2.6
2.8
32.29
26.42
umol/l
—
7
76
17
181
0.94
0.05
1.5
1.5
1.09
1.29
nmol/l
0.31
11
129
18
191
0.94
0.04
1.7
1.2
—
—
—
0
0
66
645
1.02
0.04
7.1
7.5
106.28
105.00
mmol/l
1.68
57
579
1002
9984
1.01
0.04
1.7
1.7
22.51
21.57
nmol/l
1.10
819
8331
23
241
0.95
0.04
1.3
1.2
—
—
—
0
0
234
2362
0.99
0.04
1.3
1.3
80.35
51.39
au/ml
0.86
18
163
183
1850
0.99
0.04
1.1
1.1
—
—
—
0
0
48
493
0.97
0.04
1.4
1.2
4.28
3.73
u/ml
0.12
18
190
27
281
0.96
0.04
7.2
6.6
3.13
116.94
ug/l
0.97
16
161
104
1055
0.99
0.03
2.3
2.2
0.00
0.00
g/l
-0.00
92
920
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
159
0.94
0.03
1.0
1.1
—
—
—
0
0
89
877
1.02
0.03
1.6
1.6
—
—
—
0
0
151
1495
1.01
0.03
2.4
2.2
3.51
3.66
g/l
0.62
130
1365
11
102
1.08
0.03
1.0
1.1
—
—
—
0
0
151
1496
1.01
0.02
2.4
2.2
4.24
4.29
g/l
0.44
130
1365
154
1526
1.01
0.02
1.7
1.7
—
—
—
0
0
399
3972
1.01
0.02
5.4
6.3
—
—
—
0
0
49
500
0.98
0.02
1.1
1.1
—
—
—
0
0
855
8530
1.00
0.02
2.3
2.4
2.75
2.86
mg/l
0.59
727
7383
151
1498
1.01
0.02
2.4
2.2
7.47
7.53
g/l
0.16
130
1366
23
238
0.97
0.02
1.3
1.2
—
—
—
0
0
129
1279
1.01
0.02
2.1
2.2
9.74
9.99
g/l
0.23
107
1135
141
1399
1.01
0.02
4.5
4.9
1.54
1.55
%
0.06
132
1322
12
113
1.06
0.01
2.1
2.4
0.61
0.61
mmol/l
0.01
12
113
27
263
1.03
0.01
1.4
1.4
1.34
1.18
u/ml
0.06
21
145
87
862
1.01
0.01
1.3
1.2
—
—
—
0
0
108
1088
0.99
0.01
2.2
2.2
0.02
0.02
g/l
0.01
96
977
126
1253
1.01
0.00
1.2
1.3
94.90
40.54
u/ml
—
7
80
41
404
1.02
0.00
1.4
1.5
—
—
—
0
0
57
564
1.01
0.00
2.1
1.6
—
—
—
0
0
2559
25583
1.00
0.00
23.4
21.1
330.24
330.22
g/l
0.04
2551
25463
161
1604
1.00
0.00
1.4
1.9
3.87
7.06
iu/ml
2.22
35
368
257
2564
1.00
0.00
2.5
2.4
30.60
25.00
au/ml
0.35
31
254
12
118
1.02
0.00
1.1
1.3
—
—
—
0
0
13
128
1.02
0.00
1.3
1.3
—
—
—
0
0
94
938
1.00
0.00
1.1
1.3
51.32
45.75
u/ml
—
5
120
49
495
0.99
0.00
1.3
1.3
144.57
156.87
au/ml
0.28
14
138
51
505
1.01
0.00
1.3
1.2
3.00
2.97
u/ml
0.01
18
159
19
189
1.01
0.00
1.3
1.4
11.16
12.36
u/l
0.47
19
180
174
1736
1.00
0.00
3.2
3.6
1.01
1.02
ratio
0.56
152
1565
126
1259
1.00
0.00
1.6
1.7
—
—
—
0
0
558
5583
1.00
0.00
1.8
1.7
1054.04
1190.29
nmol/l
3.27
396
4225
279
2787
1.00
0.00
1.5
1.5
—
—
—
0
0
68
683
1.00
0.00
1.6
1.8
345.13
338.79
mu/l
0.04
62
615
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
8
84
0.95
-0.00
1.0
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.0
—
—
—
0
0
8
88
0.91
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
16
160
1.00
-0.00
1.2
1.4
33.56
31.81
umol/l
0.23
16
153
0
5
0.00
-0.00
0.0
1.2
—
1.26
—
0
5
8
88
0.91
-0.00
1.1
1.3
—
—
—
0
0
8
88
0.91
-0.00
1.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
2.0
1.5
62.60
119.47
ug/l
—
5
45
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.9
—
330.50
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
2.20
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
21
210
1.00
-0.00
1.2
1.2
—
—
—
0
0
6
66
0.91
-0.00
1.3
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_INTRADUCTAL – Carcinoma in situ of breast, intraductal
GWS hits: 6
This endpoint is excluded from FinRegistry analyses (omitted endpoint).